India is cutting cancer drug prices by up to 70% after adding 137 non-scheduled anti-cancer medicines to its price control list. The move aims to make treatment more affordable in the country’s $2.6 billion oncology market, according to a statement from the Ministry of Chemicals and Fertilisers. Margins capped across all formulations The medicines include immunotherapy drugs used for 20…
Cancer Drug Prices Reduced for 137 Vital Medicines in India
